Kennedy Capital Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-147,148
Closed -$4.31M 808
2017
Q3
$4.31M Buy
+147,148
New +$4.12M 0.08% 461
2017
Q2
Sell
-310,367
Closed -$7.26M 791
2017
Q1
$7.26M Sell
310,367
-36,769
-11% -$907K 0.13% 273
2016
Q4
$8.73M Sell
347,136
-7,760
-2% -$196K 0.15% 221
2016
Q3
$9.96M Sell
354,896
-96,784
-21% -$2.48M 0.19% 174
2016
Q2
$11.1M Buy
451,680
+191,920
+74% +$4.76M 0.23% 141
2016
Q1
$5.74M Buy
259,760
+29,123
+13% +$775K 0.12% 313
2015
Q4
$8.07M Sell
230,637
-485,525
-68% -$15.2M 0.16% 215
2015
Q3
$20.4M Sell
716,162
-64,215
-8% -$2.16M 0.42% 37
2015
Q2
$26M Sell
780,377
-72,508
-9% -$2.23M 0.47% 31
2015
Q1
$24M Buy
852,885
+156,765
+23% +$3.9M 0.42% 37
2014
Q4
$14.4M Buy
696,120
+98,964
+17% +$2.35M 0.27% 99
2014
Q3
$14.6M Buy
597,156
+99,482
+20% +$2.64M 0.29% 81
2014
Q2
$14.2M Sell
497,674
-68,871
-12% -$1.92M 0.26% 109
2014
Q1
$15.9M Buy
566,545
+30,127
+6% +$740K 0.3% 82
2013
Q4
$11.5M Buy
536,418
+100,344
+23% +$1.82M 0.21% 154
2013
Q3
$5.79M Buy
436,074
+132,898
+44% +$1.79M 0.11% 344
2013
Q2
$4.2M Buy
+303,176
New +$4.3M 0.09% 399

Kennedy Capital Management's PMC Position: Q4 2017 in Review

Kennedy Capital Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 147,148 shares — an estimated $4.31M sold.

Kennedy Capital Management first reported a position in PMC in Q2 2013 and held it in 17 quarters. The position peaked at $26M in Q2 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Kennedy Capital Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Kennedy Capital Management sold 147,148 PharMerica Corporation shares in Q4 2017, an estimated $4.31M.
  • Kennedy Capital Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 17 quarters.
  • Kennedy Capital Management's PharMerica Corporation position peaked at $26M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Kennedy Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.